VERIFIED AMERICAN MANUFACTURERS

Aavis Pharmaceuticals Inc is a USFDA-approved, privately owned pharmaceutical company strategically located in Hoschton, Georgia, serving as a subsidiary of Senores Pharmaceuticals Ltd. Specializing as a Contract Development and Manufacturing Organization (CDMO/CMO), the company delivers proficiently researched high-quality pharmaceuticals with a focus on complex formulations and enhanced therapeutic efficiency. The company excels in generic drug development, offering comprehensive research and development services for both immediate and controlled release oral solid dosage forms. Their core capabilities encompass analytical method development and validation, stability studies, and seamless scale-up from research to commercial manufacturing phases. Aavis Pharmaceuticals provides critical clinical study support, enabling pharmaceutical partners to navigate complex regulatory requirements effectively. With specialized expertise in pharmaceutical formulation research, the organization develops innovative formulations designed to improve patient compliance and therapeutic outcomes. Their contract research services support clients throughout the drug development lifecycle, from initial concept to market-ready products. The company maintains rigorous quality standards while delivering cost-effective solutions for pharmaceutical manufacturers seeking reliable CDMO partnerships. Located in the thriving Atlanta region, Aavis Pharmaceuticals leverages advanced manufacturing technologies and regulatory expertise to serve domestic and international markets, establishing itself as a trusted partner in the competitive pharmaceutical manufacturing landscape.

Biopharmaceutical company focused on development and commercialization of small molecule drugs addressing unmet medical needs in central nervous system disorders. Over 30 years of experience specializing in neurological and psychiatric conditions. Notable for approved treatments in Parkinson's disease psychosis and advancing pipeline in CNS therapeutic areas.

Aclaris Therapeutics operates a research and development facility in St. Louis through its wholly-owned subsidiary Confluence Discovery Technologies. The company is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases.

Adaptive Biotechnologies operates manufacturing and quality control facilities that harness the immune system for diagnostic and therapeutic applications. They develop products for immune-driven medicine working with drug developers and clinicians.

Adare Pharma Solutions is a global technology-driven CDMO providing product development through commercial manufacturing expertise focused on oral dosage forms for the pharmaceutical industry. With over 30 years of proven legacy, Adare has successfully developed and manufactured more than 40 products sold by partners in more than 100 countries globally.

Adlon Therapeutics LP is a specialty pharmaceutical company based in Stamford, Connecticut, dedicated to developing innovative treatment solutions for patients suffering from Attention Deficit/Hyperactivity Disorder (ADHD). As a subsidiary of Purdue Pharma LP, the company leverages extensive pharmaceutical expertise to advance therapeutic options in the central nervous system disorder space. Founded in 2019, Adlon Therapeutics focuses specifically on small molecule development and ADHD treatment protocols, positioning itself as a targeted player in the neurological therapeutics market. The company operates with a clear mission to serve the ADHD community through comprehensive approaches that include developing cutting-edge medicines, promoting responsible prescription stimulant utilization, conducting meaningful research, and supporting evidence-based policies for appropriate ADHD diagnosis and treatment. Located at 201 Tresser Boulevard in Stamford, Adlon Therapeutics combines pharmaceutical manufacturing capabilities with specialized knowledge in attention deficit disorders. The company maintains a dedicated team of medical science liaisons and specialty sales representatives who work directly with healthcare providers to ensure optimal patient outcomes. Through its focused approach to ADHD therapeutics, Adlon Therapeutics continues to contribute to advancing treatment standards while maintaining commitment to patient safety and therapeutic efficacy in the specialized pharmaceutical manufacturing sector.

Advanced ChemTech, established in 1985 and headquartered in Louisville, Kentucky, stands as a leading chemical research company specializing in innovative products for pharmaceutical and research markets. As part of TCP Analytical, the company has built a reputation for delivering high-quality amino acids, peptides, resins, and coupling reagents that make research and production simpler, faster, and more reliable. The company excels in providing protected amino acids, natural and unusual amino acids, and specialized coupling reagents essential for pharmaceutical development. Their comprehensive peptide synthesis capabilities encompass both solid and solution phase methodologies, offering contract custom peptide production with various configurations and modifications. Advanced ChemTech maintains an extensive portfolio of PEG linkers, pseudoproline dipeptides, and specialized resins that support complex pharmaceutical manufacturing processes. What distinguishes Advanced ChemTech in the competitive pharmaceutical supply market is their focus on uncommon and modified amino acids, providing researchers with access to specialized compounds that are often difficult to source elsewhere. Their flexible peptide delivery options and commitment to quality ensure that pharmaceutical companies and research institutions receive precisely engineered materials that meet stringent industry standards. Operating from their Louisville facility, Advanced ChemTech continues to serve as a trusted partner for pharmaceutical manufacturers seeking reliable chemical solutions and custom synthesis services.

GMP and ISO 13485 compliant contract manufacturer specializing in lyophilization services, reagent manufacturing, and immunoassay development for diagnostics, medical device, biotechnology, and pharmaceutical markets.

Contract development and manufacturing organization (CDMO) specializing in sterile injectable pharmaceuticals. Provides aseptic manufacturing for biologics and small molecules with over 30 years of expertise, maintaining FDA-compliant systems with 99.9% on-time delivery rate.

AGC Biologics operates multiple cGMP manufacturing lines with various scales for mammalian and microbial biologics at their Bothell facility. The company provides comprehensive development and manufacturing services for therapeutic proteins, plasmid DNA, messenger RNA, viral vectors, and genetically engineered cells.

Agno Pharmaceuticals stands as a leading global Contract Development and Manufacturing Organization (CDMO) based in Bethlehem, Pennsylvania, serving the pharmaceutical industry since 2004. The company specializes in comprehensive pharmaceutical solutions spanning API development, drug product manufacturing, and analytical services for pharmaceutical, biotech, generic, and CDMO sectors worldwide. Agno excels in manufacturing regulatory starting materials, chemical intermediates, and active pharmaceutical ingredients including highly potent APIs and sterile formulations. Their advanced capabilities encompass preclinical and clinical material production, commercial manufacturing, and complex formulation development utilizing cutting-edge technologies such as milling, micronizing, nanomilling, hot melt extrusion, and injection molding. The company offers diverse dosage form expertise including injectables, parenteral products, ophthalmic formulations, oral medications, topical and transdermal applications, and specialized drug implants. Operating under GLP and cGMP manufacturing standards, Agno maintains multiple facilities including locations in Bethlehem, Pennsylvania, and two facilities in China. With their commitment to unlocking pharmaceutical innovation potential, Agno Pharmaceuticals delivers end-to-end solutions from critical API development through sterile drug product formulation, positioning themselves as a trusted partner in bringing therapeutic innovations to market efficiently and safely.

Tea and herbal product manufacturer with 42+ years of experience producing herbal teas, natural health products, and honey with A+ BBB rating serving Alaska communities.